October 26, 2021
Currax Pharmaceuticals Announces the Appointment of Ed Cinca to Senior Vice President, Global Marketing and Strategic Alliance Management
Read moreOctober 21, 2021
Currax Pharmaceuticals Granted Type C Meeting with FDA Regarding its Phase 3 Study to Evaluate the Safety and Efficacy of CX-101
Read moreSeptember 30, 2021
Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters
Read moreAugust 2, 2021
Currax Pharmaceuticals Moves Global Headquarters to Brentwood, Tennessee
Read moreJune 25, 2021